Solomon Technologies, Inc., together with its subsidiaries, engages in the development, engineering, manufacture, licensing, and sale of electric power drive systems; and the design, development, and production of customer power systems, chassis, and power supply products. It has two divisions, Power Electronics and Motive Power. The Power Electronics Division manufactures products that convert raw electrical power from sources, such as central utility, backup power, and distributed or renewable generation into electricity required by electronic and electrical equipment. This division offers a high voltage/high power line of embedded power conversion products under the brand name Cobalt15, including DC-DC converters; and low voltage products, such as AC-DC and DC-DC converters in both switching and linear configurations. It also offers a range of switching and linear power supplies, including power factor corrected, hot-swappable, and redundant units; legacy power supplies; and single unit and multiple unit size switchers, as well as custom made switchers. This division markets its products to the defense, aerospace, telecommunications, computers, networking, industrial, and medical instrumentation sectors through in-house direct sales resources and a network of manufacturer’s representatives. The Motive Power Division engages in the development, engineering, manufacture, license, and sale of electric power drive systems. This division offers electric power drive systems, electric motors, and safety power management distribution device. Its markets include recreational marine industry for original equipment manufacturer and retrofit applications, and the commercial marine industry, including lifeboats, fishing boats, motor launches, and small military water craft projects. Solomon Technologies was founded in 1992 and is based in Danbury, Connecticut.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions in the United States. Its Biometrics segment provides Vector Segment Technology SDK, a biometric development kit; True User Identification, a biometric identification solution to perform false alias checks and manage fraudulent access to systems; WEB-key, a biometric security platform for managing fingerprint authentication in unprotected networks; Biometric Service Provider that provides single user interface for multiple fingerprint readers; and ID Director that offers custom authentication scheme for companies to enhance authentication. The company’s Law Enforcement segment offers MobileCop, a wireless query and messaging application; PocketCop, a software solution for law enforcement personnel; IdentityMatch, a Web-based fingerprint biometric solutions for criminal custody agencies; Field Interview Tracker, which enables personnel to capture field contact information; Patrol Journal, an automated system to electronically capture and record users daily activities; and TStop that enables law enforcement personnel to capture the information on their mobile computer for future report generation. It also provides State Crash Report, which provides personnel to use their mobile computer to collect data needed; InfoServer, a solution for an agency’s central messaging switch; Multiple Application Programming Interface, which facilitates an agency to have multiple ports to the server to accommodate disparate interfaces; InfoExchange that offers data from local RMS and other databases directly to the mobile data user; and MobileCop Navigator, which provides mapping features, such as in-car display of location and driving directions. BIO-key International has strategic alliances with Oracle, Computer Associates, Hewlett Packard, Dell, Verizon, Sprint/Nextel, and AT&T Wireless. The company was founded in 1993 and is based in Wall, New Jersey.
BioCentric Energy Holdings, Inc., through its subsidiaries, engages in the discovery, development, and implementation of renewable energy projects. The company is in the process of implementing a solution that utilizes a technologically advanced microwave solution to produce energy from multiple waste products, such as municipal solid wastes, used tires, and Chinese tallow. It also distributes organic oils, including crude, degummed soybean oil, rapeseed oil, and palm oil to biodiesel facilities. The company is based in Beeville, Texas.
Thornburg Mortgage, Inc. operates as a residential mortgage lending company. It originates, acquires, and retains investments in adjustable and variable rate mortgage (ARM) assets. The company’s ARM assets consist of purchased ARM assets and ARM loans, including traditional ARM assets and hybrid ARM assets. It acquires and originates assets, through correspondent lending, wholesale lending, direct retail lending, and bulk acquisition programs. Thornburg Mortgage, Inc. acquires ARM assets from investment banking firms, broker-dealers, mortgage bankers, mortgage brokerage firms, banks, savings and loan institutions, credit unions, home builders, and other entities involved in originating, securitizing, packaging, and selling mortgage-backed securities and mortgage loans. It operates as an externally advised real estate investment trust (REIT). As a REIT, the company would not be subject to federal corporate income tax, provided it distributes at least 90% of taxable income to its shareholders. Thornburg Mortgage, Inc. was founded in 1992 and is based in Santa Fe, New Mexico.
THMR at 10:25 AM 12/30/2008: 8 and 20 Period SMA Both Sloping Up.
Biovest International, Inc., a biotechnology company, develops therapeutic anti-cancer vaccine for the treatment of low-grade Follicular Lymphoma in the United States. It develops BiovaxID, a Phase III clinical trial product, which is an injectable patient-specific vaccine to treat the follicular form of non-Hodgkin’s lymphoma. The company develops, manufactures, and markets cell culture systems, equipment, and consumable parts to pharmaceutical, diagnostic, and biotechnology companies, as well as to research institutions worldwide. Biovest International also produces mammalian and insect cells, monoclonal antibodies, recombinant and secreted proteins, and other cell culture products using hollow fiber perfusion. It is also developing an automated cell culture instrument, AutovaxID that enables production of personalized cell-based treatments. In addition, the company sells hollow fiber bioreactors, cultureware, tubing sets, and other disposable products and supplies. Further, Biovest International engages in the production and contract manufacture of biologic drugs and cell production for research institutions. Its customers include biopharmaceutical and biotech companies, medical schools, universities, research facilities, hospitals, and public and private laboratories. The company was incorporated in 1981 as Endotronics, Inc. and changed its name to Cellex Biosciences, Inc. in 1993. Further, it changed its name to Biovest International, Inc. in 2001. The company is based in Worcester, Massachusetts. Biovest International, Inc. is a subsidiary of Accentia Biopharmaceuticals, Inc. On November 10, 2008, Biovest International Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, Tampa, in joint administration with Accentia Biopharmaceuticals, Inc.
BVTI at 10:23 AM 12/29/2008: Price crossed above 20 day SMA.
Open Energy Corporation, a renewable energy company, focuses on the development and commercialization of a portfolio of solar technologies for residential, commercial, and industrial applications. The company designs, manufactures, and distributes building-integrated photovoltaic roofing tiles, roofing membranes, and architectural photovoltaic glass products under the “SolarSave” trade name. Open Energy Corporation is headquartered in Solana Beach, California.
